Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
OtherCONTINUING EDUCATION

Current Methods of Pharmacologic Stress Testing and the Potential Advantages of New Agents

Elias H. Botvinick
Journal of Nuclear Medicine Technology March 2009, 37 (1) 14-25; DOI: https://doi.org/10.2967/jnmt.108.057802
Elias H. Botvinick
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 37 no. 1 14-25
DOI 
https://doi.org/10.2967/jnmt.108.057802
PubMed 
19258260

Published By 
Society of Nuclear Medicine
Print ISSN 
0091-4916
Online ISSN 
1535-5675
History 
  • Received for publication September 9, 2008
  • Accepted for publication December 24, 2008
  • Published online March 2, 2009.

Copyright & Usage 
© 2009 by Society of Nuclear Medicine

Author Information

  1. Elias H. Botvinick
  1. Divisions of Cardiology and Nuclear Medicine, Departments of Medicine and Radiology, University of California San Francisco, San Francisco, California
  1. For correspondence or reprints contact: Elias H. Botvinick, Box 0214, University of California San Francisco, 505 Parnassus Ave., Room M-308, San Francisco, CA 94143-0214. E-mail: botvinicke{at}medicine.ucsf.edu
View Full Text

Statistics from Altmetric.com

Cited By...

  • 38 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Adenosine and maximum coronary vasodilation in humans: myth and misconceptions in the assessment of coronary reserve
    Gerd Heusch
    Basic Research in Cardiology 2010 105 1
  • Contributions of A2Aand A2Badenosine receptors in coronary flow responses in relation to the KATPchannel using A2Band A2A/2Bdouble-knockout mice
    Maryam Sharifi Sanjani, Bunyen Teng, Thomas Krahn, Stephen Tilley, Catherine Ledent, S. Jamal Mustafa
    American Journal of Physiology-Heart and Circulatory Physiology 2011 301 6
  • Safety of regadenoson as a pharmacologic stress agent for myocardial perfusion imaging in chronic kidney disease patients not on hemodialysis
    Gurunanthan Palani, Zehra Husain, Rafael Cabrera Salinas, Vanji Karthikeyan, Aarthee S. Karthikeyan, Karthik Ananthasubramaniam
    Journal of Nuclear Cardiology 2011 18 4
  • Does risk for major adverse cardiac events in patients undergoing vasodilator stress with adjunctive exercise differ from patients undergoing either standard exercise or vasodilator stress with myocardial perfusion imaging?
    Sanjeev U. Nair, Alan W. Ahlberg, Deborah M. Katten, Gary V. Heller
    Journal of Nuclear Cardiology 2015 22 1
  • Doppler Echocardiography Assessment of Coronary Microvascular Function in Patients With Angina and No Obstructive Coronary Artery Disease
    Jakob Schroder, Eva Prescott
    Frontiers in Cardiovascular Medicine 2021 8
  • Use of regadenoson for measurement of fractional flow reserve
    Aditya Prasad, Meena Zareh, Reece Doherty, Ambarish Gopal, Hita Vora, Keith Somma, Anilkumar Mehra, Leonardo C. Clavijo, Ray V. Matthews, David M. Shavelle
    Catheterization and Cardiovascular Interventions 2014 83 3
  • Preoperative evaluation and perioperative management of patients undergoing major vascular surgery
    Christopher Lee, Jesse A Columbo, David H Stone, Mark A Creager, Stanislav Henkin
    Vascular Medicine 2022 27 5
  • SPECT and PET in ischemic heart failure
    George Angelidis, Gregory Giamouzis, Georgios Karagiannis, Javed Butler, Ioannis Tsougos, Varvara Valotassiou, George Giannakoulas, Nikolaos Dimakopoulos, Andrew Xanthopoulos, John Skoularigis, Filippos Triposkiadis, Panagiotis Georgoulias
    Heart Failure Reviews 2017 22 2
  • Adenosine signaling pathways as potential therapeutic targets in respiratory disease
    Massimo Caruso, Angela Alamo, Emanuele Crisafulli, Cirino Raciti, Alfredo Fisichella, Riccardo Polosa
    Expert Opinion on Therapeutic Targets 2013 17 7
  • Advances in Cardiac SPECT and PET Imaging: Overcoming the Challenges to Reduce Radiation Exposure and Improve Accuracy
    Gary R. Small, R. Glenn Wells, Thomas Schindler, Benjamin J.W. Chow, Terrence D. Ruddy
    Canadian Journal of Cardiology 2013 29 3

Article usage

Article usage: March 2009 to April 2025

AbstractFullPdf
Mar 2009244275322
Apr 2009173327243
May 2009134251199
Jun 200932209154
Jul 200922174113
Aug 200935138109
Sep 20092114687
Oct 20092913367
Nov 200926164103
Dec 20092115793
Jan 20102821384
Feb 20102020078
Mar 201025211103
Apr 20101618073
May 20101718376
Jun 201017209107
Jul 20101223391
Aug 20102826893
Sep 20101525170
Oct 20102322386
Nov 20102921165
Dec 20101718970
Jan 20112419357
Feb 20112122970
Mar 20116222672
Apr 20114716953
May 20114616243
Jun 20119715947
Jul 20118813138
Aug 201111316653
Sep 201112030569
Oct 201111638475
Nov 2011113439105
Dec 20117829754
Jan 201210035789
Feb 201210239992
Mar 2012113338101
Apr 20129533466
May 20129538191
Jun 20127228459
Jul 20128941671
Aug 20127756789
Sep 201212556490
Oct 2012165720107
Nov 201219669694
Dec 2012132545105
Jan 2013163600112
Feb 201315453786
Mar 201311446363
Apr 201311546182
May 201315532469
Jun 201311522348
Jul 20137019340
Aug 20136925949
Sep 20134929745
Oct 20138323450
Nov 20135021233
Dec 20137221338
Jan 20145320129
Feb 20144821237
Mar 20146421439
Apr 20148523746
May 20146030338
Jun 20144143740
Jul 20145343993
Aug 20146338078
Sep 20144239267
Oct 20146735244
Nov 20145425048
Dec 20143725743
Jan 20153527540
Feb 20153924941
Mar 20157221850
Apr 20155918731
May 20154516034
Jun 20153514419
Jul 20155919731
Aug 20154116228
Sep 20153616422
Oct 20155418833
Nov 20151115624
Dec 2015291339
Jan 20164820519
Feb 20162916823
Mar 20164416339
Apr 20161421521
May 20163614929
Jun 20162611632
Jul 20163313627
Aug 20163713120
Sep 20162914824
Oct 20163617150
Nov 20162024772
Dec 201612327861
Jan 20173920476
Feb 20173320252
Mar 20172716864
Apr 20172810168
May 20172519486
Jun 20171521964
Jul 20172718176
Aug 20171519224
Sep 20172623617
Oct 20172121624
Nov 20172120525
Dec 20172417715
Jan 20181719328
Feb 20181020419
Mar 20182319721
Apr 20181626414
May 20181627014
Jun 20181025716
Jul 20182728125
Aug 20182036930
Sep 2018842943
Oct 20181226120
Nov 20181429327
Dec 2018719914
Jan 20191419113
Feb 20191728816
Mar 20191932825
Apr 20191234441
May 20191031923
Jun 20191425819
Jul 20191432014
Aug 20192033126
Sep 20191633643
Oct 20191920445
Nov 20192319923
Dec 2019815215
Jan 20201619525
Feb 20201525620
Mar 2020141627
Apr 20201618820
May 20201214415
Jun 2020915411
Jul 202014676
Aug 20201512411
Sep 2020912116
Oct 20201111218
Nov 202089614
Dec 202096413
Jan 2021331120
Feb 2021611111
Mar 2021510015
Apr 202129015
May 2021861112
Jun 20217104611
Jul 2021512013
Aug 2021415016
Sep 2021816318
Oct 2021516420
Nov 2021516927
Dec 2021712720
Jan 2022713618
Feb 202227216
Mar 20221211825
Apr 20221211818
May 2022915326
Jun 2022811127
Jul 2022311814
Aug 202271138
Sep 2022614312
Oct 2022913013
Nov 2022416912
Dec 202261349
Jan 20231013719
Feb 2023141649
Mar 20231219627
Apr 20231215122
May 2023921823
Jun 2023824724
Jul 2023618121
Aug 20231015724
Sep 20231014721
Oct 2023712212
Nov 2023616015
Dec 20231113017
Jan 20241523528
Feb 2024619030
Mar 2024718619
Apr 2024423819
May 20241016948
Jun 20241012631
Jul 2024414928
Aug 2024612731
Sep 2024810636
Oct 2024912027
Nov 20241214521
Dec 2024314417
Jan 2025614717
Feb 2025920313
Mar 20251522226
Apr 20251217322
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 37 (1)
Journal of Nuclear Medicine Technology
Vol. 37, Issue 1
March 2009
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Current Methods of Pharmacologic Stress Testing and the Potential Advantages of New Agents
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Current Methods of Pharmacologic Stress Testing and the Potential Advantages of New Agents
Elias H. Botvinick
Journal of Nuclear Medicine Technology Mar 2009, 37 (1) 14-25; DOI: 10.2967/jnmt.108.057802

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Current Methods of Pharmacologic Stress Testing and the Potential Advantages of New Agents
Elias H. Botvinick
Journal of Nuclear Medicine Technology Mar 2009, 37 (1) 14-25; DOI: 10.2967/jnmt.108.057802
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • EXERCISE AND PHARMACOLOGIC STRESS TESTING FOR CAD EVALUATION
    • WHEN TO PERFORM PHARMACOLOGIC STRESS TESTING
    • THE MECHANISM OF CORONARY VASODILATOR STRESS TESTING
    • NONSELECTIVE A2A ADENOSINE RECEPTOR AGONISTS
    • DOBUTAMINE STRESS
    • SELECTIVE A2A ADENOSINE RECEPTOR AGONISTS
    • A SPECULATION
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Cardiac and coronary CT comprehensive imaging approach in the assessment of coronary heart disease
  • Google Scholar

More in this TOC Section

  • Illuminating the Hidden: Standardizing Cardiac MIBG Imaging for Sympathetic Dysfunction
  • PET/CT Case Series: Unmasking the Mystery of Cardiac Sarcoidosis
  • Delivery Methods of Radiopharmaceuticals: Exploring Global Strategies to Minimize Occupational Radiation Exposure
Show more Continuing Education

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire